中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共24条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya;  Kong, Beihua;  Zheng, Hong;  Liu, Jihong;  Wu, Xiaohua;  Wang, Li;  Huang, Yi;  Wang, Ke;  Zou, Dongling;  Zhao, Hongqin;  Wang, Chunyan;  Lu, Weiguo;  Lin, An;  Lou, Ge;  Li, Guiling;  Qu, Pengpeng;  Yang, Hongying;  Zhen, Xiaoa;  Hang, Wenzhao;  Hou, Jianmei;  Banerjee, Ashish;  Wu, Lingying
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui;  Wang, Dewei;  Ran, Li;  Sun, Tao;  Zhao, Da;  Bai, Yuju;  Yang, Shun'e;  Wang, Xiaojia;  Wu, Rong;  Zeng, Xiaohua;  Yao, Herui;  Ji, Xuening;  Jiang, Jun;  Hu, Xiaohua;  Lin, Haifeng;  Zheng, Liping;  Zhu, Zhitu;  Ge, Wei;  Yang, Junlan;  Cui, Tongjian;  Zhang, Xiaozhi;  Lu, Fangyang;  Li, Wenhui;  Xu, Hongyan;  Kang, Mafei;  Gong, Ping;  Zou, Liqun;  Liu, Jiang;  Zhang, Hongliang;  Yu, Hao;  Xu, Binghe
收藏  |  浏览/下载：46/0  |  提交时间：2022/12/23
breast cancer  chemotherapy  efficacy  lobaplatin  neoplasm metastasis  safety  
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 卷号: 15
作者:  Liu, Long;  Yu, Xingxing;  Li, Zhifeng;  He, Xiaohua;  Zha, Jie;  Lin, Zhijuan;  Hong, Yan;  Zheng, Huijian;  Lai, Qian;  Ding, Kaiyang;  Jia, Xian;  Fu, Guo;  Yu, Haifeng;  Yang, Haiyan;  Li, Zhiming;  Young, Ken H.;  Xu, Bing
收藏  |  浏览/下载：30/0  |  提交时间：2022/12/23
FL  TIME  POD  Immune signature  T cells  
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li;  Wu, Xiaohua;  Yao, Desheng;  Wu, Qiang;  Liu, Jihong;  Tang, Junying;  Yin, Rutie;  Lou, Ge;  An, Ruifang;  Zhang, Guonan;  Xia, Xiaoping;  Li, Qingshui;  Zhu, Yaping;  Zheng, Hong;  Yang, Xinfeng;  Hu, Yuanjing;  Zhang, Xin;  Hao, Min;  Huang, Yi;  Lin, Zhongqiu;  Wang, Dong;  Guo, Xiaoqing;  Yao, Shuzhong;  Wan, Xiaoyun;  Zhou, Huaijun;  Yao, Liangqing;  Yang, Xielan;  Cui, Heng;  Meng, Yuanguang;  Zhang, Songling;  Qu, Jing;  Zhang, Ben;  Zou, Jianjun;  Wu, Lingying
收藏  |  浏览/下载：28/0  |  提交时间：2022/12/22
Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yin, Rutie;  Li, Ning;  Wu, Lingying;  Wang, Jing;  Zhu, Jianqing;  Pan, Lingya;  Kong, Beihua;  Zheng, Hong;  Liu, Jihong;  Wu, Xiaohua;  Wang, Li;  Huang, Yi;  Wang, Ke;  Zou, Dongling;  Zhao, Hongqin;  Wang, Chunyan;  Lu, Weiguo;  Zhen, Xiaoa;  Hang, Wenzhao;  Hou, Jianmei
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge;  Wu, Xiaohua;  Zhou, Qi;  Gao, Yunong;  Kong, Beihua;  Lu, Xin;  Wang, Jing;  Chen, Youguo;  Cheng, Ying;  Wang, Yueling;  Lu, Weiguo;  Li, Wei;  Ma, Xin;  Hsu, Kate
收藏  |  浏览/下载：51/0  |  提交时间：2022/05/05
BRCA mutation  China  olaparib  ovarian cancer  PARP inhibitor  
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Jing;  Lin, Zhongqiu;  Yin, Rutie;  Sun, Wei;  Zhou, Qi;  Zhang, Songling;  Wang, Danbo;  Shi, Hong;  Gao, Yunong;  Huang, Yi;  Li, Guiling;  Wang, Xiuli;  Cheng, Ying;  Lou, Ge;  Gao, Qinglei;  Wang, Li;  Du, Xiuping;  Pan, Mei;  Mu, Xiyan;  Li, Li;  Li, Miao;  Mu, Song;  Kong, Beihua
收藏  |  浏览/下载：72/0  |  提交时间：2022/03/28
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载：56/0  |  提交时间：2021/11/01
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载：65/0  |  提交时间：2021/11/01
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li;  Wu, Xiaohua;  Yao, Desheng;  Wu, Qiang;  Liu, Jihong;  Tang, Junying;  Yin, Rutie;  Zhang, Guonan;  Lou, Ge;  An, Ruifang;  Xia, Xiaoping;  Li, Qingshui;  Zhu, Yaping;  Hong, Zheng;  Yang, Xinfeng;  Hu, Yuanjing;  Zhang, Xin;  Wan, Xiaoyun;  Qu, Jing;  Zhang, Ben;  Wu, Lingying
收藏  |  浏览/下载：54/0  |  提交时间：2021/11/01